Prescription guidelines in cardiology
Cardiological therapy is refined day by day on the basis of clinical trials and meta-analyses, the results of which, insufficiently known or applied, have demonstrated and justified with an almost absolute strength of evidence the value of a given molecule depending on the patient's clinical state.The proposed treatment guidelines are directly derived from results of more than [...]
[lire le résumé du livre]
Auteur : Robert HAÏAT , Gérard LEROY
Editeur : Frison Roche
Date parution : 06/2012 (4ème édition)Multilingue : | Anglais |
CB Google/Apple Pay, Chèque, Virement
Quel est le sujet du livre "Prescription guidelines in cardiology"
Cardiological therapy is refined day by day on the basis of clinical trials and meta-analyses, the results of which, insufficiently known or applied, have demonstrated and justified with an almost absolute strength of evidence the value of a given molecule depending on the patient's clinical state.
The proposed treatment guidelines are directly derived from results of more than four hundred large-scale clinical trials and one hundred and a hall studies and meta-analyses, amplified and strengthened by the main guidelines of scientific societies, usually American or European.
These treatment guidelines provide the prescriber with a scientific and practical guide to the procedures and cules that now govern modern cardiological therapy in lise with the most recent scientific data.
Sommaire et contenu du livre "Prescription guidelines in cardiology"
Table of contentsPreface... 5
Foreword.... 9
Chapter 1 -Cardiovascular risk factors.. 11
A-Hypertension................................. 11
Definitions and diagnosis............ . 13
Non-pharmacological treatment 16
Pharmacological treatment . 18
HT and lVH................... 34
Hl and dyslipidemia.... 36
HT of the elderly 38
Hl and diabetes............................. 41
Hl and coronary heart disease.. 41
Hl and stroke 42
Hl and renal failure ', ,_. ' , ,.,..,.................. . ,..,.., , 43
HT and pregnancy .. , , ,',.. ,.,.......... 44
~;s~~':n~t~tn~f~I~~~ ·p·~~~~·~·;ë·~ont;~ï:: :~
8 -Dyslipidemia. 53
Non-pharmacological treatment ,. S5
Pharmacological treatment.. S6
Factual data.. .. ,............... 53
Dyslipidemia and HT 66
Dyslipidemia and diabetes 66
Chapter 2 -Diabetes..... 71
Factual data....................... 71
Definitions and diagnosis.......... . . 72
Cardiovascular risk reduction.. 73
Diabetes and hypertension 83
Diabetes and dyslipidemia 91
Oiabetes and coronary heart disease 96
Prevention of diabetes.. 98
Chapte, 3 -Stable angina. . 101
~,~t~~~?~~~1 ~[~~~i~i;~h~;;;i~.~~~~ï; .• :::............................................... . ~ g~
The prescription for patients with stable coronary heart disease.... .. 106
Myocardial revascularization .. 106
Chapter 4 -Acute coronary syndromes without persistent ST-segment elevation.. 113
Factual data 113
Risk stratification................................................... 114
Earl)' invasive strategy V5 conservative strategy 115
Antlthrombotic therapy 119
Anti-ischemic therapy 129
Coronary angioplasty V5 coronary artery bypass graft.. 130
Other drugs . 131
Chapter 5 -MyocardiaJ infarction with persistent ST-segment elevation. 135
Factual data................................................. 135
Early restoration of coronary perfusion.. 135
Primary angioplasty 140
Adjuvant therapy .. 148
Chapter 6 -Post-myocardial infarction.. 159
BASIC treatment and control of risk factors .. 159
~~r:n~~~~~·(·~·;d;o·~·~·~t·~·;~~~iëfib·~iii~t·~~·(ïëD):::: ::: :::::::::::: ~~;
Chapter 7 -Valvular heart disease 173
Chapter 8 -Pericardites. 175
Chapter 9 -Chronic heart failure.. 177
Prevention 177
Non-pharmacological treatment 178
Pharmacological treatment...... 179
~~1~~;~b~~nc~~~~~~~i~r~dt:f~b~Firat'~~'(ïëDj ~~~
Resynchronization and ICO 200
Surgical treatment 201 Ultrafiltration.................... .. 205
Improved follow-up . 205
Chapter 10 -Atrial fibrillation.... .. 209
Cardîoversion for atrial fibrillation . 209
~~~~~? 6/s~~~~trh~~~~ ::~~~~~~Ii~f~~~t·;i~~iar··~at~·::··· .:: ~U
Antithrombotic therapy. . 217
Chapter 11-Venous thromboembolism 225
Deep vein thrombosÎs. . . 225 Pulmonary embolism .. . 232
Chapter 12 -Stroke prevention ...... .. 239 Primary prevention of atherothrombotie stroke or TIA..... . 239 ~~~~~Ja~;~vr~~~~~~~~fa~h'~~~~~~~~~o~~~st·~~k~·ë·~·TiA· ::::::::::::.: ~:1 Seeondary prevention of embolie stroke or TIA. . 249 Correction of symptomatic carotid artery stenosis.. . . 249 Correction of asymptomatic carotid artery stenosis.. 251
Tables Causes of refractory HT .... 47 Cockcroft and Gault formula . 47 levey formula (MDRD) . 48 Rationale for fixed combinations of antihypertensives .. 48 Secondary hypertension .. 49 New BHS-NICE guideline, . 49 Evaluation of the ten-year eardiovascular risk -The Framingham equation .. 50 Evaluation of the ten-year cardiovascular risk -The SCORE grid 51 Conversion factors . 66 Friedewald's formula .. 66 Body mass index . 67 Risk of diabetes on statins . 67 Guidelines on the management of dyslipidemjc patients . 6B 70
~:it~~~~~es~~fd~~~f.~.~~:.i.~~.:::::::::::::::::::::::::::::::::::::::::::::::::: .. 100 Silent myocardial ischemia -Cohn's classification.. 110 SYNTAX 'core. ........ .... 110 Angina pectoris: functional classification 111 EDRF, NO and nitrates . 111 European guidelines on the treatment of stable angina peeloris. .. .. 112 TIMI risk score in ACS without ST-segment elevation . 133 Killip's classification of heart failure during acute myocardial infarction . 157 Non-steroidal anti-inflammatory druC)s (NSAIDs) inerease the eardiovaseular risk. 157
~~:a~;~;~f~~;~~~~~~~~Oa~~~j~I?~:::;.~~~s~if·i~aù·~~·:::: 158 171
Resuscilalion procedures . 172
Stages of heart failure .. 207
Measurement of leh ventricular ejection fraction (lVEF) 208
Heart failure with preserved systolic function . .. 208
Bleeding risk with oral anticoagulants: Beyth's score.... . .. 221
Classification of atrial fibrillation . .. 222
CHADS2 ,core and CHADS2DS2-VASc .. .. 222
Embolie risk .... 223
HAS-BlED Score .. .. .. 223
Target recommendations (Afssaps 9uidelines, 2009) .. ~~~ri~~~~i~~I~~~~~e:rf:~~1i~s~(~~re~kydinede~).i~ ..~~~~~~.~~.i~::: .. .. .. 235 235 ......... 236
Miller's index .. .... 237
Pulmonary embolism: essential concepts ........ Right heart thromboembolism ... .. .. 238 238
Index. .............. 253